NEXT MEETING

The Company’s primary therapeutic focus is oncology, including the treatment of chronic cancer pain, but is also developing therapeutic products for other indications, including immunology and infectious diseases. ... (LDA) whereby the Company granted Ark a license to develop and commercialize RTX for animal use only, in exchange for the ... ................
................

In order to avoid copyright disputes, this page is only a partial summary.